Sewell W - Search Results

1

Serum trough IgG level and annual intravenous immunoglobulin dose are not related to body size in patients on regular replacement therapy.

Khan S, Grimbacher B, Boecking C, Chee R, Allgar V, Holding S, Wong G, Huissoon A, Herriot R, Doré P, Sewell W. Khan S, et al. Among authors: sewell w. Drug Metab Lett. 2011 Apr;5(2):132-6. doi: 10.2174/187231211795305302. Drug Metab Lett. 2011. PMID: 21457142

2

Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients.

Khan S, Abuzakouk M, Doré PC, Sewell WA. Khan S, et al. Among authors: sewell wa. Ir J Med Sci. 2011 Mar;180(1):125-8. doi: 10.1007/s11845-010-0654-4. Epub 2010 Dec 7. Ir J Med Sci. 2011. PMID: 21136195

3

Intravenous immunoglobulin-induced neutropenia.

Khan S, Doré PC, Sewell WA. Khan S, et al. Among authors: sewell wa. Pediatr Allergy Immunol. 2010 Aug;21(5):892-3. doi: 10.1111/j.1399-3038.2009.00885.x. Epub 2009 Apr 3. Pediatr Allergy Immunol. 2010. PMID: 19368688 No abstract available.

4

Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project.

Holding S, Khan S, Sewell WA, Jolles S, Dore PC. Holding S, et al. Ann Clin Biochem. 2015 May;52(Pt 3):319-26. doi: 10.1177/0004563214545791. Epub 2014 Jul 14. Ann Clin Biochem. 2015. PMID: 25024432

5

Do ribosomopathies explain some cases of common variable immunodeficiency?

Khan S, Pereira J, Darbyshire PJ, Holding S, Doré PC, Sewell WA, Huissoon A. Khan S, et al. Among authors: sewell wa. Clin Exp Immunol. 2011 Jan;163(1):96-103. doi: 10.1111/j.1365-2249.2010.04280.x. Epub 2010 Nov 9. Clin Exp Immunol. 2011. PMID: 21062271 Free PMC article. Review.

6

Risks of intravenous immunoglobulin in sepsis affect trial design.

Khan S, Sewell WA. Khan S, et al. Among authors: sewell wa. Ann Intern Med. 2007 Dec 4;147(11):813; author reply 813-4. doi: 10.7326/0003-4819-147-11-200712040-00017. Ann Intern Med. 2007. PMID: 18056670 No abstract available.

7

Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia.

Khan S, Del-Duca C, Fenton E, Holding S, Hirst J, Doré PC, Sewell WA. Khan S, et al. Among authors: sewell wa. J Clin Pathol. 2009 May;62(5):439-41. doi: 10.1136/jcp.2008.060509. J Clin Pathol. 2009. PMID: 19398595

8

Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome.

Khan S, Holding S, Doré PC, Sewell WA. Khan S, et al. Among authors: sewell wa. Med Hypotheses. 2008;70(2):269-72. doi: 10.1016/j.mehy.2007.05.048. Epub 2007 Jul 30. Med Hypotheses. 2008. PMID: 17664047

9

Antibody deficiency.

Herriot R, Sewell WA. Herriot R, et al. Among authors: sewell wa. J Clin Pathol. 2008 Sep;61(9):994-1000. doi: 10.1136/jcp.2007.051177. J Clin Pathol. 2008. PMID: 18755724 Review.

10

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

Khan S, Doré PC, Sewell WA. Khan S, et al. Among authors: sewell wa. Pediatr Allergy Immunol. 2008 Mar;19(2):186-7. doi: 10.1111/j.1399-3038.2007.00658.x. Pediatr Allergy Immunol. 2008. PMID: 18257907 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page